This post is part of a monthly blog series profiling viewpoints from leaders in reproductive health who are members of the Bellagio Group on Long-Acting Reversible Contraception. The Bellagio Group is a coalition of experts who convene annually to discuss practices for expanding contraceptive choice and accelerating progress toward the Millennium Development Goal of universal access to reproductive health services. This post represents the views of the authors, and is not a representation of the Population Council or the Bellagio Group. Please direct any questions to the author at email@example.com.
Affordability is often considered one of the biggest barriers to accessing medicines and medical technologies, including contraceptives. But ensuring that a full range of medicines and technologies are universally accessible takes more than just an affordable price; it requires an interconnected web of partners within and outside a national health system who share a commitment to reaching men and women with the supplies they need, when and where they need them.